“Boasting over 2,000 posters and multiple sessions covering all fields of oncology, this year’s ASCO meeting promises to be packed full of intense, fruitful exchanges. For yet another year, a great many Institut Curie doctors will be attending to present their original, breakthrough research,” explains Prof. Steven Le Gouill, Director of the Institut Curie Hospital Group. “From immunotherapy and new treatment combinations to real-world data studies and the clinical value of circulating biomarkers, Institut Curie’s presentations are a testimony to the excellence and international reach enjoyed by our teams, all of whom work tirelessly for an ever better level of care and treatment for cancer patients”.
- Key Points –
BREAST CANCER/Circulating biomarkers: analyzing the role they play in the blood in patients with metastatic hormone receptor-positive breast cancer
HEMATOLOGY/The long-term benefits of immunotherapy on mantle cell lymphoma after autologous transplantation
EPIDRUGS AND IMMUNOTHERAPY/Highly encouraging results in squamous cell cancers
CANCER VACCINES/A study on an anti-HPV-16 therapeutic vaccine for anogenital cancers and a trial on personalized vaccines for ENT cancers
LUNG CANCER/Conclusive studies into real-world data in small cell lung cancer and research into thrombosis risk prevention